SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Community sentiment remains heavily polarized as traders weigh the potential market impact of ongoing geopolitical tensions and new economic sanctions against Iran, while others focus on speculative talk of an upcoming merger catalyst.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing selling pressure as investors track launch schedule updates and institutional activity while the stock navigates a broader sector-wide pullback. Community sentiment remains polarized, with long-term investors highlighting partnerships and growth catalysts while others express frustration over management transparency regarding satellite deployments.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is drawing community attention as investors debate its long-term potential as a payment collateral utility versus its prolonged downward price action. Discussions center on whether the project is at a major accumulation point or facing structural decline, with participants closely monitoring legislative developments and institutional interest in crypto payment rails.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSTR is surging as community members discuss a new multibillion-dollar cash pool while Bitcoin trends higher, sparking intense debate between bulls expecting a short squeeze and bears skeptical of ongoing share dilution. The stock remains a focal point for retail traders who are actively tracking its correlation with Bitcoin's momentum and the company's aggressive capital allocation strategy.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trading higher as the broader crypto sector rallies on expectations surrounding a White House meeting with industry executives to discuss the Clarity Act and Treasury liquidity measures. Community sentiment is sharply divided between optimistic investors targeting further upside in the crypto bull run and skeptical traders who view the recent move as a temporary rally in a struggling stock.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia shares are under pressure as investors navigate pre-earnings uncertainty and broader semiconductor sector weakness, with community discussions polarized between those expecting a 'lights out' blowout quarter and skeptics citing concerns over circular financing and geopolitical trade risks. Despite the volatility, many participants are viewing the pullback as a buying opportunity ahead of key data-center and AI infrastructure updates scheduled for this week.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

UAMY is trending after a sharp sell-off sparked by significantly lowered full-year revenue guidance and a Q2 earnings miss, with investors pointing to lower antimony market prices and execution delays. The community remains polarized, with some bulls emphasizing the company's long-term monopoly status and strategic importance to domestic defense, while others express frustration over management's communication and the volatility of its growth narrative.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is experiencing bullish momentum as the company expands its oncology and immunology portfolio, driven by positive data for its HIV treatments and strong market interest in its cell therapy advancements. The community is actively discussing Gilead's strategic acquisitions and the durability of its core HIV franchise, positioning the stock as a key player in current institutional healthcare rotation.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is facing intense market pressure following an FDA clinical hold on its experimental Hunter syndrome gene therapy, RGX-121, after asymptomatic spinal abnormalities were discovered in trial participants. While the company stated that investigators and radiologists consider these findings benign and reported no neurocognitive decline, investors are expressing frustration over the lack of a near-term path forward and are debating whether the stock's current price is an extreme overreaction to the regulatory setback.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is currently trending as investors debate whether the stock has found a structural bottom after recent insider buying and institutional accumulation following a steep decline. While some market participants are cautious due to debt concerns and ongoing procedure volume questions, the community is actively discussing potential long-term value, with many monitoring insider activity as a key indicator of confidence in the company's future growth initiatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The community is actively debating the recent reverse stock split for the leveraged ETF, with some expressing frustration over price action while others see it as a strategic holding opportunity amidst Bitcoin's volatile rally. Investors remain hyper-focused on the fund's sensitivity to MicroStrategy's price movements and the broader crypto market sentiment.

Michael Saylor Says ‘Fixing The Credit’ Takes Priority Over MSTR Stock Buybacks 

Equity

During the Q2 earnings call, Saylor said a stronger credit business could ultimately support a higher equity premium for MSTR shareholders.


Michael Saylor’s Strategy Raises $333M Selling MSTR Stock, Leaves Bitcoin Stash Untouched

The pause in Strategy’s Bitcoin sales comes after the company sold 6,948 BTC for roughly $431.8 million since late May.


MSTR Stock Gains After Michael Saylor’s Strategy Extends Bitcoin Buying Pause To Two Weeks, While Raising Another $263.5M 

The company has now gone four consecutive weeks without increasing its Bitcoin position, including two weeks of sales followed by two weeks without purchases.


Bitcoin Bear Sees BTC Sliding Toward $10K, Says Strategy’s Saylor Must Be ‘Stopped Out’

The comments follow Strategy's $216 million sale of Bitcoin on Monday to fund its STRC preferred stock program.

Could The US Ever Bail Out Bitcoin? Some Say Strategy Makes The Idea Harder To Dismiss

Cryptocurrency

The piece warned that Strategy selling Bitcoin into a falling market could turn reflexive, deepening its liquidity needs.

Strategy Says It Can Sell Bitcoin To Fund Buybacks, Dividends Without Abandoning BTC Bet

A minimum reserve policy of 12 months' coverage has been set, with any reductions requiring Board authorization.

Bitcoin Is Having Its Toughest June Since 2022 – But Saylor Sees Another Buying Opportunity 

CryptoQuant sees an early bottoming signal, while Strategy faces scrutiny over funding and dividend obligations.

MSTR Stock Slumps To Two-Year Low As Analysts Urge Michael Saylor To Pause Buying Bitcoin 

The slide deepened a steep drawdown for the stock, which crypto key opinion leader Ted Pillows said had fallen roughly 81% from its peak, erasing about $153 billion in market value.


Strategy's Financing Engine 'Has Started To Creak' After STRC Wipeout Week, Analysts Warn 

As STRC trades below par, on-chain expert Axel Adler Jr. claimed Strategy's financing mechanism "started to creak".


Arthur Hayes Says Michael Saylor Is Pulling 'Jedi Mind Tricks' On Whether Strategy Will Sell More Bitcoin

Strategy sold 32 BTC for roughly $2.5 million in late May, its first standalone Bitcoin sale since 2022.


ETF Opportunities Trust - T-Rex 2X Long MSTR Daily Target ETF

Extremely Bullish Sentiment

Beat EPS and revenue 

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

Nvidia ($NVDA) reports Q2 earnings Wednesday with Wall Street expecting roughly $91.7 billion in revenue — about 80% year-over-year growth — and EPS near $2.08. What do you expect in terms of revenue and EPS? Vote and explain your reasoning in the comments.

What do you expect from Nvidia ($NVDA) earnings on Wednesday?

Feed

News

Sentiment

Fundamentals

Info